Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT03477812 Recruiting - Nocturnal Enuresis Clinical Trials

Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study

Start date: January 22, 2018
Phase:
Study type: Observational

Full ambulatory polysomnography at home performed two nights in 30 healthy children and one night in 30 children with mono-symptomatic nocturnal enuresis (15 with polyuria and 15 without polyuria). The children will be aged 7-14 years of age. The sleep will be evaluated on sleep quality, number of periodic limb movements per hour, blood pressure and pulse, beat to beat variation by electrocardiography during sleep, respiration during sleep, nocturnal urine production, and enuresis episodes.

NCT ID: NCT03477214 Completed - Clinical trials for Urinary Incontinence

Tactile Imaging and Electromyography

Start date: December 24, 2017
Phase:
Study type: Observational

Urinary incontinence (UI) and overactive bladder (OAB) in women has high prevalence which is increasing with the age. In adults aged 40 and older in the US demonstrated prevalence rate of 27.2% among man and 43.1% among women, respectively. Urine Incontinence was reported to affect 15% of women ages 40 to 49, 25% ages 60 to 69, and 38% of women age 80 and older.

NCT ID: NCT03474653 Active, not recruiting - Clinical trials for Urinary Incontinence

LATITUDE An Observational Study of Patient Choice and the Urethral Bulking Agent, Bulkamid®

Start date: June 12, 2017
Phase:
Study type: Observational

Latitude is an observational study exploring how effective Bulkamid ® is as a first line treatment for women with stress urinary incontinence. Women who choose to have Bulkamid as part of their standard clinical care will be asked to complete questionnaires before and after their surgery so that we can assess how their urinary symptoms change. As a second part of the study, we are asking all patients having any first line treatment for stress incontinence to complete a short questionnaire telling us how they decided what treatment to have. A small number of these women will be contacted via telephone and asked whether they would mind being interviewed to tell us more about this. We will also interview a number of doctors taking part in Latitude to find out how they counsel patients about different treatment options for stress urinary incontinence.

NCT ID: NCT03473041 Not yet recruiting - Clinical trials for Stress Urinary Incontinence

Autologous Rectus Sheath Fascia Versus Midurethral Transobturator Tension Free Vaginal

Start date: March 2018
Phase: Phase 3
Study type: Interventional

a hybrid sling formed of a central part of autologus rectus sheath (2×6 cm) and two arms of polypropylene mesh (2×10cm) versus transobturator tension free vaginal tape(TVT-O)

NCT ID: NCT03468465 Active, not recruiting - Clinical trials for Urinary Incontinence

Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome

SOLITENS
Start date: May 4, 2018
Phase: Phase 4
Study type: Interventional

- To determine if the T-PTNS is not inferior in the short term (3 months) to one of the usual pharmacological treatments (Solifenacin) in the treatment of hyperactive bladder syndrome and with respect to the percentage of patients that improve 50% any of the 3 signs (Urinary frequency, diurnal / nocturnal frequency, urgency and urinary incontinence). - To determine prognostic factors associated with insufficient improvement (less than 50% in the 3 main signs of hyperactive bladder syndrome (urinary frequency, urgency and urinary incontinence frequency) after treatment with T-PTNS and Solifenacin.

NCT ID: NCT03463863 Completed - Clinical trials for Stress Urinary Incontinence

Midurethral Sling With Autologus Rectus Sheath

Start date: August 10, 2016
Phase: Phase 3
Study type: Interventional

assessment of the safety and efficacy surgeon tailored rectus sheath midurethral sling

NCT ID: NCT03450902 Completed - Clinical trials for Urinary Incontinence

Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence

Start date: March 14, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether combination therapy with Chinese herbal formula, Yiqi Suoquan granule, and acupuncture is effective in the treatment of female mixed urinary incontinence.

NCT ID: NCT03443687 Completed - Quality of Life Clinical Trials

Systematized Quality Exercise Alternatives for Stress Incontinence

SQEASI
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This randomized controlled study evaluates the effect of home biofeedback compared to pelvic floor physical therapy for the treatment of stress urinary incontinence. Half of the participants will use a home biofeedback device for 3 months and the other half will attend pelvic floor physical therapy appointments for 3 months.

NCT ID: NCT03438422 Completed - Clinical trials for Urinary Incontinence

Effect of Pollen Extract on Urinary Incontinence

Start date: December 21, 2017
Phase: Phase 3
Study type: Interventional

Study with food supplement to assess the eficacy of pollen extract on Urinary Incontinence

NCT ID: NCT03401983 Completed - Clinical trials for Stress Urinary Incontinence

Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence. This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT "Pelvic Floor Muscle Training" and 32 PFMT+AT "Abdominal Training") by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.